Israel - hebraisk - Ministry of Health

padagis israel agencies ltd, israel - vinorelbine as tartrate - קפסולות - vinorelbine as tartrate 20 mg - vinorelbine - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.

Israel - hebraisk - Ministry of Health

perrigo israel agencies ltd - remifentanil as hydrochloride - אבקה לשיקום להכנת תמיסה לזריקה - remifentanil as hydrochloride 1 mg/vial - remifentanil - remifentanil - ultiva is indicated for i.v. administration as an analgesic for use during induction and maintenance of general anaesthesia for inpatient and outpatient procedures under direct supervision of an anesthetist. remifentanil is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Israel - hebraisk - Ministry of Health

perrigo israel agencies ltd - remifentanil as hydrochloride - אבקה לשיקום להכנת תמיסה לזריקה - remifentanil as hydrochloride 2 mg/vial - remifentanil - remifentanil - ultiva is indicated for i.v. administration as an analgesic for use during induction and maintenance of general anaesthesia for inpatient and outpatient procedures under direct supervision of an anesthetist. remifentanil is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Israel - hebraisk - Ministry of Health

padagis israel agencies ltd, israel - remifentanil as hydrochloride - אבקה לשיקום להכנת תמיסה לזריקה - remifentanil as hydrochloride 5 mg/vial - remifentanil - remifentanil - ultiva is indicated for i.v. administration as an analgesic for use during induction and maintenance of general anaesthesia for inpatient and outpatient procedures under direct supervision of an anesthetist. remifentanil is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Israel - hebraisk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - lidocaine as hydrochloride; methylprednisolone acetate - תרחיף להזרקה - lidocaine as hydrochloride 10 mg/ml; methylprednisolone acetate 40 mg/ml - methylprednisolone, combinations - lidocaine - depo-medrol with lidocaine is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: - synovitis of osteoarthritis - rheumatoid arthritis - acute and subacute bursitis - acute gouty arthritis - epicondylitis - acute nonspecific tenosynovitis - post-traumatic osteoarthritis.

Israel - hebraisk - Ministry of Health

teva pharmaceutical indust.ltd - dipyrone 1 g / 2 ml - solution for injection - metamizole sodium - as an analgesic: optalgin injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. intravenous administration of dipyrone should be carried out slowly over a period of at least 5 minutes, followed by reasonable clinical observation. intramuscular administration of dipyrone for relief of pain is not recommended.however, if medical circumstances require such administration, all due precautions should be exercised to permit reasonable clinical observation. as an antipyretic: optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.

Israel - hebraisk - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

Israel - hebraisk - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

Israel - hebraisk - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

Israel - hebraisk - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.